In addition, in order to investigate the role of CXCR4 in the progression of pancreatic cancer, the present study also analyzed the association between the expression profiles of CXCR4 and clinicopathological factors only in tumor tissues from 33 patients with PDAC (Table 3). This evidence concerns the gene CXCR4 and neoplasm.